NYSE · LH
Labcorp Holdings Inc.
$311.10 +$14.33 (+4.83%) 1D Market open
Session Pulse
Regular session
1
mentions on Wed
· 1 bullish
/ 0 bearish tags
No new SEC filings since Mon close
its sector ranked
5/11
this week
Full pulse →
Key Metrics
$24.34B
Market cap
25.85×
P/E · TTM
$14.14B
Revenue · TTM
$941.50M
Net income
EPS · TTM
$11.17
Dividend yield
1.0%
Free cash flow
$1.38B
Beta · 1Y
0.22
EBITDA · TTM
$2.13B
Gross margin
28.8%
Snapshot
Market cap$24.34B
Enterprise value$29.69B
Shares outstanding82.0M
52-wk range$244.52 – $301.79
Avg volume · 20D757.0K
Net cash
−$5.35B
Book value / share$103.54
IndustryServices-Medical Laboratories
ExchangeNYSE
About Labcorp Holdings Inc.
IPO dateJul 7, 1988
Employees71000
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market.
Wolf Grade COMING SOON
—
The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.
Valuation
P/E25.85
P/S1.72
P/FCF17.58
EV/EBITDA13.96
EV/Sales2.10
Graham №$161.30
Profitability
Gross
28.8%
Operating
10.2%
Net
6.7%
FCF
9.8%
ROE / ROIC
11.2% · —
Financial Health
Current ratio1.73
Quick ratio1.54
Debt / equity0.73
Debt / EBITDA
2.98
Net cash
−$5.35B
Working capital$1.92B
Cash Flow · TTM
Operating CF
$1.81B
Capex
−$429.50M
Free cash flow
$1.38B
Buybacks
—
Dividends paid
$240.30M
Shareholder yield
1.0%
Piotroski F-Score
7 / 9
Strong fundamentals · 7 of 9 signals passing
Altman Z-Score
3.2
Safe zone (> 2.99) · bankruptcy risk negligible
Graham Number vs Price
$161.30 vs $301.17
Trades 1.9× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings